Thank you for registering for the 4th Glioblastoma Drug Development Summit 2023.
You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation.
If you have any questions about your registration, please contact
Telephone: (+1) 617 455 4188
Email: customersupport@hansonwade.com
We look forward to welcoming you to the conference.
Precision Oncology
Accelerating the Development of More Effective & Precise Oncology Therapies to Targeted Patient Populations
Conferences
Covering the breadth of precision oncology drug development, our sector-defining conferences on ADCs, targeted radiopharmaceuticals, companion diagnostics, and bispecifics provide the insight you need to deliver more effective treatments for patients in need.
Data
Beacon Cancer Vaccine covers trial and drug records for clinical, preclinical, approved, and discontinued prophylactic and therapeutic cancer vaccines to help you track the cancer vaccine-related clinical trial and drug landscape.
Research
A trusted provider of market intelligence for anyone looking to understand the complexities of precision oncology research and development.